| Metric | სს ინოვას | შპს ნეოფარმი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.0m₾1.9m | ₾19.2m₾15.4m |
| Revenue growth | 165.0% | 25.0% |
| Profitability | ||
| EBITDA | ₾2.8m₾549k | -₾376k-₾1.3m |
| EBITDA margin | 56.5%29.1% | -2.0%-8.5% |
| Net profit | ₾2.7m₾378k | -₾589k-₾1.5m |
| Net margin | 54.8%20.0% | -3.1%-9.5% |
| Balance sheet | ||
| Total assets | ₾6.3m₾4.0m | ₾8.0m₾8.5m |
| Total equity | ₾5.5m₾3.2m | ₾5.1m₾6.1m |
| ROE | 49.8%11.7% | -11.6%-23.8% |